97 related articles for article (PubMed ID: 31792853)
1. Serum SCUBE-1 levels in patients with diabetic retinopathy.
Icel E; Icel A; Mertoglu C; Tasli NG; Karakurt Y; Ucak T; Gunay M
Int Ophthalmol; 2020 Apr; 40(4):859-865. PubMed ID: 31792853
[TBL] [Abstract][Full Text] [Related]
2. The relationship of serum SCUBE-1, -2 and -3 levels with clinical findings and ultrasonographic skin thickness in systemic sclerosis patients.
Gündüz İ; Batmaz İ; Bozan T; Ekinci A; Cevik R
Int J Rheum Dis; 2020 Apr; 23(4):526-531. PubMed ID: 31991528
[TBL] [Abstract][Full Text] [Related]
3. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy.
Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K
BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349
[TBL] [Abstract][Full Text] [Related]
4. Association of serum N(ε)-Carboxy methyl lysine with severity of diabetic retinopathy.
Mishra N; Saxena S; Shukla RK; Singh V; Meyer CH; Kruzliak P; Khanna VK
J Diabetes Complications; 2016 Apr; 30(3):511-7. PubMed ID: 26782022
[TBL] [Abstract][Full Text] [Related]
5. Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis?
Capkin AA; Demir S; Mentese A; Bulut Ç; Ayar A
Arch Dermatol Res; 2017 Apr; 309(3):203-207. PubMed ID: 28238185
[TBL] [Abstract][Full Text] [Related]
6. Plasma level of miR-93 is associated with higher risk to develop type 2 diabetic retinopathy.
Zou HL; Wang Y; Gang Q; Zhang Y; Sun Y
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1159-1166. PubMed ID: 28382439
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of SCUBE-1 levels as a placental dysfunction marker at gestational diabetes mellitus.
Bayoglu Tekin Y; Baki Erin K; Yilmaz A
Gynecol Endocrinol; 2020 May; 36(5):417-420. PubMed ID: 31668102
[No Abstract] [Full Text] [Related]
8. Elevated serum fetuin-A levels are associated with grades of retinopathy in type 2 diabetic patients.
Yilmaz A; Yilmaz T; Gunay M
Int Ophthalmol; 2018 Dec; 38(6):2445-2450. PubMed ID: 29071522
[TBL] [Abstract][Full Text] [Related]
9. Serum and vitreous fibulin-1 concentrations in patients with diabetic retinopathy.
Tian M; Wang J; Wei Y; Lu Q; Huang B
J Investig Med; 2016 Oct; 64(7):1209-12. PubMed ID: 27422995
[TBL] [Abstract][Full Text] [Related]
10. Association of Plasma Pentraxin-3 Levels with Retinopathy and Systemic Factors in Diabetic Patients.
Erdenen F; Güngel H; Altunoğlu E; Şak D; Müderrisoğlu C; Koro A; Akça Güler P; Hakan Sahin ME; Simsek G; Uzun H
Metab Syndr Relat Disord; 2018 Sep; 16(7):358-365. PubMed ID: 30036122
[TBL] [Abstract][Full Text] [Related]
11. Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.
Koleva-Georgieva DN; Sivkova NP; Terzieva D
Folia Med (Plovdiv); 2011; 53(2):44-50. PubMed ID: 21797106
[TBL] [Abstract][Full Text] [Related]
12. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
[TBL] [Abstract][Full Text] [Related]
13. Increased serum periostin concentrations are associated with the presence of diabetic retinopathy in patients with type 2 diabetes mellitus.
Ding Y; Ge Q; Qu H; Feng Z; Long J; Wei Q; Zhou Q; Wu R; Yao L; Deng H
J Endocrinol Invest; 2018 Aug; 41(8):937-945. PubMed ID: 29349642
[TBL] [Abstract][Full Text] [Related]
14. Low blood and vitreal BDNF, LXA4 and altered Th1/Th2 cytokine balance are potential risk factors for diabetic retinopathy.
Kaviarasan K; Jithu M; Arif Mulla M; Sharma T; Sivasankar S; Das UN; Angayarkanni N
Metabolism; 2015 Sep; 64(9):958-66. PubMed ID: 26004392
[TBL] [Abstract][Full Text] [Related]
15. Can signal peptide-CUB-EGF domain-containing protein 1 (SCUBE-1) be used as an indicator of endothelial dysfunction in acromegaly patients?
Tufekci D; Nuhoglu I; Ayan SS; Gunay YE; Coskun H; Bilginer MC; Ucuncu O; Kocak M; Yaman SO; Karahan SC
Endocrine; 2023 Oct; 82(1):152-160. PubMed ID: 37450216
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum OxLDL is associated with progression of type 2 Diabetes Mellitus to diabetic retinopathy.
Kuppan K; Mohanlal J; Mohammad AM; Babu KA; Sen P; Undurti ND; Natarajan V; Narayanasamy A
Exp Eye Res; 2019 Sep; 186():107668. PubMed ID: 31100308
[TBL] [Abstract][Full Text] [Related]
17. Plasma
Jiang Q; Lyu XM; Yuan Y; Wang L
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108673
[TBL] [Abstract][Full Text] [Related]
18. Serum uric acid concentration is associated with worsening in severity of diabetic retinopathy among type 2 diabetic patients in Taiwan--a 3-year prospective study.
Lee JJ; Yang IH; Kuo HK; Chung MS; Chen YJ; Chen CH; Liu RT
Diabetes Res Clin Pract; 2014 Nov; 106(2):366-72. PubMed ID: 25108898
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like 3 Is a Potential Biomarker for Retinopathy in Type 2 Diabetic Patients.
Yu CG; Yuan SS; Yang LY; Ke J; Zhang LJ; Lang JN; Zhang DW; Zhao SZ; Zhao D; Feng YM
Am J Ophthalmol; 2018 Jul; 191():34-41. PubMed ID: 29621508
[TBL] [Abstract][Full Text] [Related]
20. Relation of serum and vitreous nesfatin-1 concentrations with diabetic retinopathy.
Dai R; Deng G; Sun Z; Liu Z; Qian Y; Han Y
J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 28079928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
